Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue

NCT04240639 is registered in ClinicalTrials.gov with Nanospectra Biosciences, Inc. as lead sponsor.

NCT NCT04240639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04240639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Lead sponsor
Nanospectra Biosciences, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
January 30, 2020
Completion date
June 30, 2023
Enrollment
60 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms of the prostate